ClinicalTrials.gg
Sign In

BRL Medicine Inc. clinical trials

Also known as Bioray Laboratories, Bangyao.

The registry lists 24 studies whose lead sponsor is BRL Medicine Inc.. 14 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jul 21, 2026.

Our grouping of 1 registry name, not the registry’s. See them and correct one ↓

Get an email when these change. Save the BRL Medicine Inc. studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Pipeline: 2 programmes

Each counted once: 2 with a study BRL Medicine Inc. leads registered in the last two years.

  • Phase 1

The 2 programmes — sign in to see the list, free: with every programme, filter by condition or phase and sort by first study or next readout.

“Registry” is the highest phase of BRL Medicine Inc.’s own registered studies; BRL Medicine Inc.’s own pipeline document is not read yet. “Next readout” is the earliest primary completion date still ahead among its live studies, as the registry states it (most are estimates). Programmes are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs BRL Medicine Inc.’s studies test, most open studies first — 3 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

3 of BRL Medicine Inc.’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. 1N’26
  2. D
  3. J’27
  4. F
  5. 1M
  6. A
  7. M
  8. J
  9. J
  10. 1A
  11. S
  12. O
  13. N

All 3

Add all 3 to your calendar (.ics) → With an account.

All 24 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now1458%Not yet recruiting 6 · Recruiting 6 · Enrolling by invitation 2
  • Under way, not recruiting14%
  • Completed313%
  • Stopped early625%Suspended 4 · Withdrawn 1 · Terminated 1

Phase

  • Phase 17
  • Phase 23
  • Early Phase 11

Where

Over the years

  1. 18
  2. 19
  3. 20
  4. 21
  5. 22
  6. 23
  7. 724
  8. 25
  9. 026

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to BRL Medicine Inc..

  • Bioray Laboratories
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    24 studies

Studies

Recruiting first, then most recently updated. Showing 24 of 24.